CoChat

Vitexin, an HIF-1α Inhibitor, Has Anti-metastatic Potential in PC12 Cells

Open access
Choi, Hwa Jung, Eun, Jae Soon, Kim, Bang Geul, Kim, Sun Yeou, Jeon, Hoon, Soh, Yunjo · 2006 · Molecules and Cells
Cited by 72

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Vitexin, a natural flavonoid compound identified as apigenin-8-C-β-D-glucopyranoside, has been reported to exhibit antioxidative and anti-inflammatory properties. In this study, we investigated its effect on hypoxiainducible factor-1α (HIF-1α) in rat pheochromacytoma (PC 12), human osteosarcoma (HOS) and human hepatoma (HepG2) cells. Vitexin inhibited HIF-1α in PC12 cells, but not in HOS or HepG2 cells. In addition, it diminished the mRNA levels of hypoxia-inducible genes such as vascular endothelial growth factor (VEGF), smad3, aldolase A, enolase 1, and collagen type HI in the PC12 cells. We found that vitexin inhibited the migration of PC12 cells as well as their invasion rates, and it also inhibited tube formation by human umbilical vein endothelium cells (HUVECs). Interestingly, vitexin inhibited the hypoxia-induced activation of c-jun N- terminal kinase (JNK), but not of extracellular-signal regulated protein kinase (ERK), implying that it acts in part via the JNK pathway. Overall, these results suggest the potential use of vitexin as a treatment for diseases such as cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1016-8478(23)17423-1

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 72

Metadata

Authors
Choi, H. J., Eun, J. S., Kim, B. G., Kim, S. Y., Jeon, H., & Soh, Y.
Venue
Molecules and Cells
Publisher
Elsevier BV
Published
2006-12
Volume
22
Issue
3
Pages
291-299
ISSN
  • 0219-1032 (ISSN-L)
  • 1016-8478
OpenAlex
W4390473007
Cited by
72
References
3
FWCI
1.70
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vitexin, an HIF-1α Inhibitor, Has Anti-metastatic Potential in PC12 Cells. https://app.cochat.ai/papers/10.1016/s1016-8478(23)17423-1
The paper
Choi, H. J., Eun, J. S., Kim, B. G., Kim, S. Y., Jeon, H., & Soh, Y. (2006). Vitexin, an HIF-1α Inhibitor, Has Anti-metastatic Potential in PC12 Cells. Molecules and Cells. https://doi.org/10.1016/s1016-8478(23)17423-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.